Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,968 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Cefepime monotherapy for febrile neutropenia in patients with lung cancer.
Saito H, Takahashi K, Okuno M, Saka H, Imaizumi K, Hasegawa Y, Tanikawa Y, Yamamoto M, Taniguchi H, Shindoh J, Suzuki R, Shimokata K; Central Japan Lung Study Group. Saito H, et al. Among authors: taniguchi h. J Infect Chemother. 2014 Jun;20(6):365-9. doi: 10.1016/j.jiac.2014.02.002. Epub 2014 Mar 26. J Infect Chemother. 2014. PMID: 24679653 Clinical Trial.
Interstitial lung disease associated with gefitinib.
Kataoka K, Taniguchi H, Hasegawa Y, Kondoh Y, Kimura T, Nishiyama O, Imaizumi K, Kawabe T, Kume H, Shimokata K. Kataoka K, et al. Among authors: taniguchi h. Respir Med. 2006 Apr;100(4):698-704. doi: 10.1016/j.rmed.2005.07.015. Epub 2005 Aug 30. Respir Med. 2006. PMID: 16137874 Free article.
A phase II study of carboplatin and paclitacel with meloxicam.
Suzuki R, Yamamoto M, Saka H, Taniguchi H, Shindoh J, Tanikawa Y, Nomura F, Gonda H, Imaizumi K, Hasegawa Y, Shimokata K. Suzuki R, et al. Among authors: taniguchi h. Lung Cancer. 2009 Jan;63(1):72-6. doi: 10.1016/j.lungcan.2008.04.002. Epub 2008 May 21. Lung Cancer. 2009. PMID: 18499296 Clinical Trial.
Serum KL-6 in fibrotic NSIP: Correlations with physiologic and radiologic parameters.
Sakamoto K, Taniguchi H, Kondoh Y, Johkoh T, Sumikawa H, Kimura T, Nishiyama O, Kato K, Kataoka K, Ono K, Kitaichi M, Hasegawa Y. Sakamoto K, et al. Among authors: taniguchi h. Respir Med. 2010 Jan;104(1):127-33. doi: 10.1016/j.rmed.2009.08.011. Epub 2009 Oct 6. Respir Med. 2010. PMID: 19811899 Free article.
Second-line weekly paclitaxel in resistant or relapsed non-small cell lung cancer treated with docetaxel and carboplatin: a multi-center phase II study.
Ichikawa M, Suzuki R, Kataoka K, Noda Y, Shindoh J, Matsumoto S, Tanikawa Y, Suzuki K, Baba K, Shindo Y, Kondo M, Imaizumi K, Kume H, Hasegawa Y, Takagi K, Taniguchi H. Ichikawa M, et al. Among authors: taniguchi h. Lung Cancer. 2010 Sep;69(3):319-22. doi: 10.1016/j.lungcan.2009.11.021. Epub 2010 Jan 6. Lung Cancer. 2010. PMID: 20053476 Clinical Trial.
Prognostic factors in rapidly progressive interstitial pneumonia.
Kondoh Y, Taniguchi H, Kataoka K, Kato K, Suzuki R, Ogura T, Johkoh T, Yokoi T, Wells AU, Kitaichi M; Tokai Diffuse Lung Disease Study Group. Kondoh Y, et al. Among authors: taniguchi h. Respirology. 2010 Feb;15(2):257-64. doi: 10.1111/j.1440-1843.2009.01687.x. Epub 2010 Jan 11. Respirology. 2010. PMID: 20070584
2,968 results